{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T08:09:56Z","timestamp":1743149396046,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":20,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493977031"},{"type":"electronic","value":"9781493977048"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7704-8_7","type":"book-chapter","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T15:22:26Z","timestamp":1520349746000},"page":"111-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Validation of a Chemiluminescence Immunoassay for Measuring Amyloid-\u03b2 in Human Blood Plasma"],"prefix":"10.1007","author":[{"given":"Jonathan","family":"Vogelgsang","sequence":"first","affiliation":[]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[]},{"given":"Hans W.","family":"Klafki","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, \u00d6hrfelt A, Portelius E, Bjerke M, H\u00f6ltt\u00e4 M, Ros\u00e9n C, Olsson C, Strobel G, Wu E, Dakin K, Petzold M, Blennow K, Zetterberg H (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 15:673\u2013684. https:\/\/doi.org\/10.1016\/S1474-4422(16)00070-3","journal-title":"Lancet Neurol"},{"issue":"4","key":"7_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1471-4159.2006.04404.x","volume":"101","author":"J Wiltfang","year":"2007","unstructured":"Wiltfang J, Esselmann H, Bibl M et al (2007) Amyloid beta peptide ratio 42\/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load. J Neurochem 101(4):1053\u20131059. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04404.x","journal-title":"J Neurochem"},{"issue":"3","key":"7_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/acn3.274","volume":"3","author":"S Janelidze","year":"2016","unstructured":"Janelidze S, Zetterberg H, Mattsson N et al (2016) CSF Abeta42\/Abeta40 and Abeta42\/Abeta38 ratios: better diagnostic markers of Alzheimer disease. Ann Clin Transl Neurol 3(3):154\u2013165. https:\/\/doi.org\/10.1002\/acn3.274","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"7_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3233\/JAD-160398","volume":"54","author":"HW Klafki","year":"2016","unstructured":"Klafki HW, Hafermann H, Bauer C et al (2016) Validation of a commercial chemiluminescence immunoassay for the simultaneous measurement of three different amyloid-beta peptides in human cerebrospinal fluid and application to a clinical cohort. J Alzheimers Dis 54(2):691\u2013705. https:\/\/doi.org\/10.3233\/JAD-160398","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"7_CR5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3233\/JAD-160722","volume":"55","author":"P Lewczuk","year":"2017","unstructured":"Lewczuk P, Matzen A, Blennow K et al (2017) Cerebrospinal fluid Abeta42\/40 corresponds better than Abeta42 to amyloid PET in Alzheimer\u2019s disease. J Alzheimers Dis 55(2):813\u2013822. https:\/\/doi.org\/10.3233\/JAD-160722","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"7_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3233\/JAD-2011-111418","volume":"28","author":"O Hansson","year":"2012","unstructured":"Hansson O, Stomrud E, Vanmechelen E et al (2012) Evaluation of plasma Abeta as predictor of Alzheimer\u2019s disease in older individuals without dementia: a population-based study. J Alzheimers Dis 28(1):231\u2013238. https:\/\/doi.org\/10.3233\/JAD-2011-111418","journal-title":"J Alzheimers Dis"},{"key":"7_CR7","doi-asserted-by":"publisher","unstructured":"Gronewold J, Todica O, Klafki HW et al (2016) Association of plasma beta-amyloid with cognitive performance and decline in chronic kidney disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-016-0243-2","DOI":"10.1007\/s12035-016-0243-2"},{"issue":"6","key":"7_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/alzrt56","volume":"2","author":"H Zetterberg","year":"2010","unstructured":"Zetterberg H, Mattsson N, Blennow K et al (2010) Use of theragnostic markers to select drugs for phase II\/III trials for Alzheimer disease. Alzheimers Res Ther 2(6):32. https:\/\/doi.org\/10.1186\/alzrt56","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"7_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13195-016-0225-7","volume":"8","author":"L Song","year":"2016","unstructured":"Song L, Lachno DR, Hanlon D et al (2016) A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-beta 1-42 peptide in human plasma with utility for studies of Alzheimer\u2019s disease therapeutics. Alzheimers Res Ther 8(1):58. https:\/\/doi.org\/10.1186\/s13195-016-0225-7","journal-title":"Alzheimers Res Ther"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fneur.2015.00179","volume":"6","author":"U Andreasson","year":"2015","unstructured":"Andreasson U, Perret-Liaudet A, van Waalwijk van Doorn LJ et al (2015) A practical guide to immunoassay method validation. Front Neurol 6:179. https:\/\/doi.org\/10.3389\/fneur.2015.00179","journal-title":"Front Neurol"},{"issue":"7","key":"7_CR11","doi-asserted-by":"publisher","first-page":"A712","DOI":"10.1021\/Ac00258a001","volume":"55","author":"GL Long","year":"1983","unstructured":"Long GL, Winefordner JD (1983) Limit of detection. Anal Chem 55(7):A712\u2013A724. https:\/\/doi.org\/10.1021\/Ac00258a001","journal-title":"Anal Chem"},{"issue":"12","key":"7_CR12","first-page":"112","volume":"18","author":"V Thomsen","year":"2003","unstructured":"Thomsen V, Schatzlein D, Mercuro D (2003) Limits of detection in spectroscopy. Spectroscopy 18(12):112\u2013114","journal-title":"Spectroscopy"},{"issue":"10","key":"7_CR13","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/JCM.32.10.2441-2447.1994","volume":"32","author":"BD Plikaytis","year":"1994","unstructured":"Plikaytis BD, Holder PF, Pais LB et al (1994) Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol 32(10):2441\u20132447","journal-title":"J Clin Microbiol"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jnc.13527","volume":"137","author":"LJ Doorn van Waalwijk van","year":"2016","unstructured":"van Waalwijk van Doorn LJ, Koel-Simmelink MJ, Haussmann U et al (2016) Validation of soluble APP assays as diagnostic CSF biomarkers for neurodegenerative diseases. J Neurochem 137:112\u2013121. https:\/\/doi.org\/10.1111\/jnc.13527","journal-title":"J Neurochem"},{"issue":"6","key":"7_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1365-3016.2008.00969.x","volume":"22","author":"BW Whitcomb","year":"2008","unstructured":"Whitcomb BW, Schisterman EF (2008) Assays with lower detection limits: implications for epidemiological investigations. Paediatr Perinat Epidemiol 22(6):597\u2013602. https:\/\/doi.org\/10.1111\/j.1365-3016.2008.00969.x","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"2","key":"7_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-2012-120058","volume":"30","author":"AD Watt","year":"2012","unstructured":"Watt AD, Perez KA, Rembach AR et al (2012) Variability in blood-based amyloid-beta assays: the need for consensus on pre-analytical processing. J Alzheimers Dis 30(2):323\u2013336. https:\/\/doi.org\/10.3233\/JAD-2012-120058","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"7_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00702-006-0511-9","volume":"113","author":"P Lewczuk","year":"2006","unstructured":"Lewczuk P, Kornhuber J, Wiltfang J (2006) The German competence net dementias: standard operating procedures for the neurochemical dementia diagnostics. J Neural Transm 113(8):1075\u20131080. https:\/\/doi.org\/10.1007\/s00702-006-0511-9","journal-title":"J Neural Transm"},{"key":"7_CR18","unstructured":"Alzheimer\u2019s Disease Neuroimaging Initiative 2 (ADNI 2) procedures manual. https:\/\/adni.loni.usc.edu\/wp-content\/uploads\/2008\/07\/adni2-procedures-manual.pdf . Accessed 6 Jan 2017"},{"key":"7_CR19","unstructured":"Thermo Fisher Scientific, Good Laboratory Pipetting Guide (2010). https:\/\/fscimage.fishersci.com\/images\/D16542~.pdf . Accessed 6 Jan 2017"},{"key":"7_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/00365519109104608","volume":"51","author":"WG Wood","year":"1991","unstructured":"Wood WG (1991) Matrix effects in immunoassays. Scand J Clin Lab Invest 51:105\u2013112. https:\/\/doi.org\/10.3109\/00365519109104608","journal-title":"Scand J Clin Lab Invest"}],"container-title":["Methods in Molecular Biology","Biomarkers for Alzheimer\u2019s Disease Drug Development"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7704-8_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T01:35:35Z","timestamp":1603935335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7704-8_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493977031","9781493977048"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7704-8_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2018]]}}}